Emerging studies suggest Retatru tide , a dual activator targeting both the gut-brain axis and another hormone, may provide a notable development for weight management . Early human trials have demonstrated considerable decreases in abdominal mass , conceivably outperforming other obesity medications . However , more study is necessary to fully ass